Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: VTAK )

0.4185 -0.0035 (-0.83%)
Streaming Delayed Price Updated: 1:57 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VTAK

< Previous 1 2 3 4 5 6 Next >
“Catheter Precision, Inc. (NYSE American: VTAK) Achieves 50 Patents Milestone for LockeT, Unveils Leadership Transition”
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors
Via ACCESSWIRE
Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market
Via ACCESSWIRE
“Holiday Season Stock Surge: Exploring Potential Opportunities for 2024” INBS, VTAK, KAVL, CLNV, BULT
Via AB Newswire
Exposures Product Safety
Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
Via ACCESSWIRE
Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
Via ACCESSWIRE
Catheter Precision Showcasing its Innovative 3D Mapping System
Via ACCESSWIRE
Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Releases Q2 2023 Financials and Corporate Highlights
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Reported Results for Q2 2023
Catheter Precision, Inc. Common Stock just reported results for the second quarter of 2023. 
Via InvestorPlace
CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
Via ACCESSWIRE
“Unlocking Potential: Emerging Growth’s Rising Stars Look Now! ASPI, VTAK, INBS, HNRC
Via AB Newswire
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023
Via ACCESSWIRE
Catheter Precision Inc. (NYSE American: VTAK) Spotlighted in “Cardiac Rhythm News” for Revolutionary Advances in Cardiac Treatment”
Via AB Newswire
Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
Via ACCESSWIRE
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
Via AB Newswire
Exposures Product Safety
“Unleashing a Medical Revolution: Transformative Breakthroughs in Diagnosis and Treatment” VTAK, ALDX, MNPR, INBS, SIEN
Via AB Newswire
Exposures Product Safety
Catheter Precision (NYSEAMERICAN: VTAK) “Revolutionizing Cardiac Arrhythmia Diagnosis: VIVO™ 3D Mapping System vs. Traditional Methods”
Via AB Newswire
Exposures Product Safety
Catheter Precision Inc. (NYSEAMERICAN: VTAK) Revolutionizing Heart Health, VTAK, LMDX, AKU, INPX, AZN
Via AB Newswire
“Discoveries Unlocked: Nasdaq Small-Cap Biotech Medical Stocks Emerge” VTAK, MNTS, MREO, PCSA, MTNB
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Nasdaq/NYSE Stocks Ignite Multiple Buzzers (AVTX, SPCB, INTZ)
Via AB Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 647 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
“2023’s Stocks to Watch Under $1 Unveiled: VTAK, AXLA, NVOS, MRIN, KAVL
Via AB Newswire
Catheter Precision Secures New Distribution Partner for Southeast Asia
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
  During Monday, 102 stocks hit new 52-week lows. 
Via Benzinga
Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
Via ACCESSWIRE
Catheter Precision (NYSE American: VTAK): Unveiling the Extraordinary Potential of an Emerging Medical Technology Powerhouse
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.